...
首页> 外文期刊>Addiction >An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam.
【24h】

An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam.

机译:在阿姆斯特丹进入或重新进入美沙酮治疗后的头2周内,服药过量死亡率增加。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIMS: It has been suggested that starting and temporarily discontinuing methadone treatment is related to an increased risk in overdose mortality. This study describes the incidence of overdose mortality in relation to time after (re)entering or leaving treatment. DESIGN: A dynamic cohort of 5200 Amsterdam methadone clients was observed during treatment and (a maximum of 1 year) after treatment. FINDINGS: Between 1986 and 1998, 29 729 person-years (py) and 68 overdose deaths were recorded, leading to an overdose mortality rate of 2.3/1000 py (2.2 during and 2.4 after treatment). A modest increase was observed during the first 2 weeks after (re)entering treatment; 6.0/1000 py (rate ratio: 2.9; 95% confidence interval 1.4; 5.8). Directly after leaving treatment no increase was observed. CONCLUSIONS: Inhaling heroin, common among Amsterdam heroin users, is thought to account for low OD mortality rates both during and after treatment. Accumulation of methadone, inadequate assessment of tolerance of known clients re-entering treatment and concurrent periods of stress or extreme heroin use when entering treatment are mentioned as possible explanations of the increased risk within the first 2 weeks. An Australian study reported a much higher increase. The modest increase in Amsterdam is explained by low background risk of overdose mortality, low starting dosage and the low threshold to treatment.
机译:目的:已建议开始和暂时中止美沙酮治疗与过量死亡的风险增加有关。这项研究描述了(重新)进入或离开治疗后与时间相关的用药过量死亡率的发生率。设计:在治疗过程中和治疗后(最多1年)观察到5200名阿姆斯特丹美沙酮客户的动态队列。结果:在1986年至1998年之间,记录了29 729人年(py)和68例过量用药死亡,导致过量使用死亡率为2.3 / 1000 py(治疗期间为2.2 /治疗后2.4)。在(重新)进入治疗后的前两周内观察到适度的增加;年利率6.0 / 1000(汇率比率:2.9; 95%置信区间1.4; 5.8)。离开治疗后直接未观察到增加。结论:阿姆斯特丹海洛因使用者中常见的吸入海洛因被认为是治疗期间和治疗后OD死亡率低的原因。提到美沙酮的积累,对已知患者重新进入治疗的耐受性评估不足以及进入治疗时同时出现压力或极端使用海洛因的情况,可能解释了头两周内风险增加。一项澳大利亚的研究报告了更高的增长。阿姆斯特丹的适度增加是由于过量死亡的低背景风险,低起始剂量和低治疗阈值所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号